MOS vs REGN · P/E 161, rev $11.12B vs P/E 14, rev $14.34B
The Mosaic Company (MOS) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
The Mosaic Company (MOS) is a agricultural inputs company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported MOS revenue for 2024-12-31 was $11.12B. Net income was $202.0M. Revenue was down 18.8% from 2023-12-31 to 2024-12-31. MOS currently screens at market cap $7.15B and trailing P/E 160.8.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
MOS currently screens at market cap $7.15B and trailing P/E 160.8. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the MOS and REGN stock pages for the full models.
Not investment advice.